لقد اجتاحت روسيا أوكرانيا في 24 فبراير/شباط 2022. قفوا مع أوكرانيا وادعمونا في كفاحنا من أجل الحرية والديمقراطية في أوروبا.  قف مع أوكرانيا!  انضم إلينا
search
منصة السياحة الطبية رقم 1 منذ عام 2014

S Eroglu

دكتور انف واذن وحنجرة

12سنة خبره ١٦ سنة

Dr. S Eroglu is a medical professional, specializing in several fields, including Septoplasty and Nasal polyp surgery. Dr. Eroglu's professional journey is characterized by involvement in clinical trials and research, especially in targeted therapies and combination immunotherapeutics for melanoma. The doctor has also focused on improving opioid delivery in an inpatient setting and has led a successful Quality Improvement project in this area. Dr. Eroglu has contributed to numerous medical publications.

الموقع

C L I N I S T A ® Hair Clinic ,إسطنبول , تركيا

اكتشف أفضل الباقات لهذا الموسم

clinic image
clinic image clinic image
انقر لرؤية المزيد حول الحزمة
تركيا, إسطنبول
C L I N I S T A ® Hair Clinic
عملية تجميل الأنف القياسية مشمولة
عيادة جديدة
كل الحزمة الشاملة

Dr. S Eroglu is a dedicated medical professional, deeply involved in clinical trials, research, and the creation of personalized treatment strategies. The doctor specializes in procedures like Septoplasty and Nasal polyp surgery, among others, and has led successful initiatives to enhance health care delivery systems.

Education

  • Dr. Eroglu earned an MD degree and is board certified in Internal Medicine - Medical Oncology. The doctor completed a residency in Internal Medicine at the University of California, Irvine, and a fellowship in Hematology/Oncology at the City of Hope/Harbor-UCLA Medical Center.

Awards

  • Dr. Eroglu's Quality Improvement (QI) project focused on improving the delivery of opioids in an inpatient setting and was selected as the winning QI project by the American College of Physicians (ACP).

Publications

  • Dr. Eroglu has contributed to diverse publications, with topics encompassing the efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy and circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.